1      0

Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29


Immunotherapeutic approach for treatment of advanced hepatocellular carcinoma: a systematic review.


Mar 22, 2021 12:00am ‐ Mar 22, 2021 12:00am

Description

Immunotherapeutic approach for treatment of advanced hepatocellular carcinoma: a systematic review. Dmitrii Shek 1,2,3, Scott A. Read 1,2,3, Adnan Nagrial 4, Matteo S. Carlino 4, Bo Gao3, Golo Ahlenstiel 1,2,3 1. Blacktown Clinical School and Research Centre, Western Sydney University, Blacktown, NSW, Australia 2. Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia 3. Blacktown Hospital, Blacktown, NSW, Australia 4. Westmead Hospital, Westmead, NSW, Australia Background Hepatocellular carcinoma (HCC) is a primary liver malignancy. Kinase inhibitors are standard of care (SoC) for metastatic HCC with median overall survival (mOS) of

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content